Efforts to develop therapeutic agents for bacterial infections to fight against AMR
Antimicrobial resistance (AMR) poses a global threat, but few new antimicrobials are in development. The G7 has been focusing on AMR since 2015, and the 2023 G7 Hiroshima Leaders’ Communiqué aims to explore push and pull incentives. The World Health Assembly adopted the Global Action Plan on AMR in 2015, and Japan developed its first action plan in 2016. A partnership between SHIONOGI, GARDP, and CHAI aims to improve access to cefiderocol in low- and middle-income countries.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!
